HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
72:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
DifferentiAl DiAGnOsis Of COPD:@0.076182:0.472665:0.384409:0.472665:0.384409:0.452500:0.076182:0.452500:0.012935:0.005174:0.008870:0.008870:0.009609:0.010718:0.009609:0.013674:0.007761:0.005174:0.013674:0.008131:0.005174:0.012935:0.005174:0.013674:0.015522:0.013674:0.015522:0.009609:0.005174:0.009609:0.005174:0.015522:0.008870:0.005174:0.014413:0.015522:0.010348:0.012935
You  may  find  symptoms  of  COPD  in  other  chronic  ill:@0.076190:0.488519:0.475907:0.488519:0.475907:0.472736:0.076190:0.472736:0.008950:0.009903:0.009192:0.004188:0.002797:0.014182:0.010326:0.008104:0.004188:0.002797:0.003681:0.003681:0.009223:0.010357:0.004188:0.002797:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.002812:0.009903:0.004747:0.004188:0.002797:0.012292:0.013138:0.008950:0.011249:0.004188:0.002797:0.003024:0.009223:0.004188:0.002797:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.002782:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004188:0.002797:0.003024:0.003024:0.003024
-:@0.475938:0.488519:0.480957:0.488519:0.480957:0.472736:0.475938:0.472736:0.005020
nesses, which  need  to  be investigated.  see  Table 1, :@0.076190:0.502581:0.485145:0.502581:0.485145:0.486799:0.076190:0.486799:0.009223:0.009827:0.005866:0.005866:0.009827:0.005866:0.004188:0.007726:0.012564:0.009223:0.003024:0.009782:0.009223:0.004188:0.003523:0.009223:0.009827:0.009827:0.010357:0.004188:0.003523:0.005125:0.009903:0.004188:0.003523:0.010311:0.009827:0.007726:0.003024:0.009223:0.008376:0.009827:0.005866:0.005125:0.003024:0.010175:0.010326:0.005125:0.009827:0.010357:0.004188:0.004188:0.003538:0.007529:0.009827:0.009827:0.004188:0.003523:0.006441:0.010326:0.010311:0.003024:0.009827:0.007726:0.008376:0.004188:0.004188
adapted from the :@0.076190:0.516644:0.213169:0.516644:0.213169:0.500861:0.076190:0.500861:0.010326:0.010357:0.010326:0.010311:0.005125:0.009827:0.010357:0.004309:0.004747:0.004551:0.009903:0.014182:0.004294:0.005125:0.009223:0.009827:0.004188
Global Initiative for Chronic Obstruc-:@0.213290:0.516644:0.480942:0.516644:0.480942:0.500861:0.213290:0.500861:0.013184:0.003024:0.009903:0.010311:0.010326:0.003024:0.004309:0.003417:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.008376:0.009827:0.004309:0.004747:0.009903:0.004551:0.004294:0.012292:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004294:0.013138:0.010311:0.005866:0.005125:0.004551:0.009192:0.009782:0.005020
tive Lung Diseases Guideline:@0.076190:0.530706:0.283215:0.530706:0.283215:0.514924:0.076190:0.514924:0.005125:0.003024:0.008376:0.009827:0.004188:0.006985:0.009192:0.009223:0.010175:0.004188:0.011249:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005866:0.004188:0.013184:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827
.:@0.283215:0.530706:0.287403:0.530706:0.287403:0.514924:0.283215:0.514924:0.004188
1:@0.287407:0.525424:0.292265:0.525424:0.292265:0.516270:0.287407:0.516270:0.004858
Differential diagnosis of a COPD exacerbation:@0.076190:0.561861:0.448119:0.561861:0.448119:0.543530:0.076190:0.543530:0.011759:0.004032:0.004704:0.004704:0.010751:0.005376:0.010751:0.010079:0.005040:0.004032:0.011087:0.004032:0.004704:0.011087:0.004032:0.011087:0.011087:0.010079:0.010751:0.007392:0.004032:0.007392:0.004704:0.010751:0.004704:0.004704:0.011087:0.004704:0.013103:0.014111:0.009407:0.011759:0.004704:0.010751:0.009407:0.011087:0.010751:0.010751:0.005376:0.011087:0.011087:0.005040:0.004032:0.010751:0.010079
A patient with established COpD may have an exacerba-:@0.076190:0.578101:0.480942:0.578101:0.480942:0.562318:0.076190:0.562318:0.010886:0.003553:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.003553:0.012262:0.002721:0.004823:0.008920:0.003553:0.009525:0.005564:0.004823:0.010024:0.010009:0.002721:0.002721:0.005564:0.008920:0.009525:0.010054:0.003553:0.011989:0.012836:0.008648:0.010946:0.003553:0.013879:0.010024:0.007801:0.003553:0.008920:0.010024:0.008074:0.009525:0.003553:0.010024:0.008920:0.003553:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.005020
tion in which symptoms of cough, sputum production and :@0.076190:0.592163:0.485175:0.592163:0.485175:0.576381:0.076190:0.576381:0.004823:0.002721:0.009601:0.008920:0.003659:0.002721:0.008920:0.003659:0.012262:0.008920:0.002721:0.009480:0.008920:0.003659:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.005564:0.003659:0.009601:0.004445:0.003659:0.009480:0.009601:0.008890:0.009873:0.008920:0.003886:0.003659:0.005564:0.010009:0.008890:0.004823:0.008890:0.013879:0.003659:0.010009:0.004248:0.009601:0.010054:0.008890:0.009480:0.004823:0.002721:0.009601:0.008920:0.003659:0.010024:0.008920:0.010357:0.004188
dyspnoea suddenly increase. Any or all symptoms may :@0.076190:0.606226:0.485175:0.606226:0.485175:0.590443:0.076190:0.590443:0.010054:0.007801:0.005564:0.010009:0.008920:0.009601:0.009525:0.010024:0.006547:0.005564:0.008890:0.010054:0.010054:0.009525:0.008920:0.002721:0.007801:0.006547:0.002721:0.008920:0.009480:0.004248:0.009525:0.010024:0.005564:0.009525:0.003886:0.006547:0.010886:0.008920:0.007801:0.006547:0.009601:0.004248:0.006547:0.010024:0.002721:0.002721:0.006547:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.005564:0.006547:0.013879:0.010024:0.008104:0.004188
get worse. An exacerbation is defined as the worsening :@0.076190:0.620288:0.485160:0.620288:0.485160:0.604505:0.076190:0.604505:0.009873:0.009525:0.004823:0.005700:0.012262:0.009601:0.004248:0.005564:0.009525:0.003886:0.005700:0.010886:0.008920:0.005700:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.005700:0.002721:0.005564:0.005700:0.010054:0.009525:0.003530:0.003530:0.008920:0.009525:0.010054:0.005700:0.010024:0.005564:0.005700:0.004823:0.008920:0.009525:0.005700:0.012262:0.009601:0.004248:0.005564:0.009525:0.008920:0.002721:0.008920:0.010175:0.004188
of symptoms that requires a change in medication and/or :@0.076190:0.634350:0.485206:0.634350:0.485206:0.618568:0.076190:0.618568:0.009601:0.004445:0.003341:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.005564:0.003341:0.004823:0.008920:0.010024:0.004823:0.003341:0.004248:0.009525:0.010009:0.008890:0.002721:0.004248:0.009525:0.005564:0.003341:0.010024:0.003341:0.009480:0.008920:0.010024:0.008920:0.009873:0.009525:0.003341:0.002721:0.008920:0.003341:0.013879:0.009525:0.010054:0.002721:0.009480:0.010024:0.004823:0.002721:0.009601:0.008920:0.003341:0.010024:0.008920:0.010054:0.006305:0.009601:0.004551:0.004188
admission to hospital. The American Thoracic society (ATs) :@0.076190:0.648413:0.485191:0.648413:0.485191:0.632630:0.076190:0.632630:0.010024:0.010054:0.013879:0.002721:0.005564:0.005564:0.002721:0.009601:0.008920:0.003130:0.004823:0.009601:0.003130:0.008920:0.009601:0.005564:0.010009:0.002721:0.004823:0.010024:0.002721:0.003886:0.003130:0.006138:0.008920:0.009525:0.003130:0.010886:0.013879:0.009525:0.004248:0.002721:0.009480:0.010024:0.008920:0.003130:0.006138:0.008920:0.009601:0.004248:0.010024:0.009480:0.002721:0.009480:0.003130:0.007227:0.009601:0.009480:0.002721:0.009525:0.004823:0.007801:0.003130:0.005277:0.010886:0.006138:0.007227:0.005579:0.004188
and the European Respiratory society (ERs) classify exac-:@0.076190:0.662475:0.480987:0.662475:0.480987:0.646692:0.076190:0.646692:0.010024:0.008920:0.010054:0.004445:0.004823:0.008920:0.009525:0.004445:0.007801:0.008890:0.004248:0.009601:0.010009:0.009525:0.010024:0.008920:0.004445:0.008875:0.009525:0.005564:0.010009:0.002721:0.004248:0.010024:0.004823:0.009601:0.004248:0.007801:0.004445:0.007227:0.009601:0.009480:0.002721:0.009525:0.004823:0.007801:0.004445:0.005277:0.007801:0.008875:0.007227:0.005277:0.004445:0.009480:0.002721:0.010024:0.005564:0.005564:0.002721:0.004445:0.007801:0.004445:0.009525:0.006955:0.010024:0.009480:0.005020
erbations as level I if there are mild or moderate symptoms :@0.076190:0.676537:0.485130:0.676537:0.485130:0.660755:0.076190:0.660755:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.003372:0.010024:0.005564:0.003372:0.002721:0.009525:0.008074:0.009525:0.002721:0.003372:0.003115:0.003372:0.002721:0.004445:0.003372:0.004823:0.008920:0.009525:0.004248:0.009525:0.003372:0.010024:0.004248:0.009525:0.003372:0.013879:0.002721:0.002721:0.010054:0.003372:0.009601:0.004248:0.003372:0.013879:0.009601:0.010054:0.009525:0.004248:0.010024:0.004823:0.009525:0.003372:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.005866:0.004188
that can be treated at home and respond to short-acting :@0.076190:0.690600:0.485145:0.690600:0.485145:0.674817:0.076190:0.674817:0.004823:0.008920:0.010024:0.004823:0.003674:0.009480:0.010024:0.008920:0.003674:0.010009:0.009525:0.003674:0.004823:0.004248:0.009525:0.010024:0.004823:0.009525:0.010054:0.003674:0.010024:0.004823:0.003674:0.008920:0.009601:0.013879:0.009525:0.003674:0.010024:0.008920:0.010054:0.003674:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.010054:0.003674:0.004823:0.009601:0.003674:0.005564:0.008920:0.009601:0.004248:0.004823:0.004717:0.010024:0.009480:0.004823:0.002721:0.008920:0.010175:0.004188
beta agonists or antimuscarinic agents. Level II exacerba-:@0.076190:0.704662:0.480987:0.704662:0.480987:0.688879:0.076190:0.688879:0.010009:0.009525:0.004823:0.010024:0.003840:0.010024:0.009873:0.009601:0.008920:0.002721:0.005564:0.004823:0.005564:0.003840:0.009601:0.004248:0.003840:0.010024:0.008920:0.004823:0.002721:0.013879:0.008890:0.005564:0.009480:0.010024:0.004248:0.002721:0.008920:0.002721:0.009480:0.003840:0.010024:0.009873:0.009525:0.008920:0.004823:0.005564:0.003886:0.003840:0.006683:0.009525:0.008074:0.009525:0.002721:0.003840:0.003115:0.003115:0.003840:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.005020
tion is a hospitalisation that responds to antibiotics and :@0.076190:0.718724:0.485145:0.718724:0.485145:0.702942:0.076190:0.702942:0.004823:0.002721:0.009601:0.008920:0.006804:0.002721:0.005564:0.006804:0.010024:0.006804:0.008920:0.009601:0.005564:0.010009:0.002721:0.004823:0.010024:0.002721:0.002721:0.005564:0.010024:0.004823:0.002721:0.009601:0.008920:0.006804:0.004823:0.008920:0.010024:0.004823:0.006804:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.010054:0.005564:0.006804:0.004823:0.009601:0.006804:0.010024:0.008920:0.004823:0.002721:0.010009:0.002721:0.009601:0.004823:0.002721:0.009480:0.005564:0.006804:0.010024:0.008920:0.010357:0.004188
corticosteroids with the short-acting agents. Level III is res-:@0.076190:0.732787:0.481003:0.732787:0.481003:0.717004:0.076190:0.717004:0.009480:0.009601:0.004248:0.004823:0.002721:0.009480:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.002721:0.010054:0.005564:0.004490:0.012262:0.002721:0.004823:0.008920:0.004490:0.004823:0.008920:0.009525:0.004490:0.005564:0.008920:0.009601:0.004248:0.004823:0.004717:0.010024:0.009480:0.004823:0.002721:0.008920:0.009873:0.004490:0.010024:0.009873:0.009525:0.008920:0.004823:0.005564:0.003886:0.004490:0.006683:0.009525:0.008074:0.009525:0.002721:0.004490:0.003115:0.003115:0.003115:0.004490:0.002721:0.005564:0.004490:0.004248:0.009525:0.005564:0.005020
piratory failure.  The most common cause for an exacer-:@0.076190:0.746849:0.480955:0.746915:0.480955:0.731132:0.076190:0.731066:0.010009:0.002721:0.004248:0.010024:0.004823:0.009601:0.004248:0.007801:0.004248:0.004445:0.010024:0.002721:0.002721:0.008890:0.004248:0.009525:0.004188:0.011307:0.004233:0.006138:0.008920:0.009525:0.004248:0.013879:0.009601:0.005564:0.004823:0.004233:0.009480:0.009601:0.013879:0.013879:0.009601:0.008920:0.004248:0.009480:0.010024:0.008890:0.005564:0.009525:0.004233:0.004445:0.009601:0.004248:0.004233:0.010024:0.008920:0.004233:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:-0.123847
1,7:@0.180364:0.741616:0.192158:0.741616:0.192158:0.732462:0.180364:0.732462:0.004683:0.002254:0.004858
bation is a bacterial or viral infection and sometimes they :@0.076188:0.760977:0.485113:0.760977:0.485113:0.745195:0.076188:0.745195:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.004279:0.002721:0.005564:0.004279:0.010024:0.004279:0.010009:0.010024:0.009480:0.004823:0.009525:0.004248:0.002721:0.010024:0.002721:0.004279:0.009601:0.004248:0.004279:0.008074:0.002721:0.004248:0.010024:0.002721:0.004279:0.002721:0.008920:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.004279:0.010024:0.008920:0.010054:0.004279:0.005564:0.009601:0.013879:0.009525:0.004823:0.002721:0.013879:0.009525:0.005564:0.004279:0.004823:0.008920:0.009525:0.008104:0.004188
are combined, as a bacterial infection is superimposed on :@0.076188:0.775040:0.485173:0.775040:0.485173:0.759257:0.076188:0.759257:0.010024:0.004248:0.009525:0.003235:0.009480:0.009601:0.013879:0.010009:0.002721:0.008920:0.009525:0.010054:0.003886:0.003235:0.010024:0.005564:0.003235:0.010024:0.003235:0.010009:0.010024:0.009480:0.004823:0.009525:0.004248:0.002721:0.010024:0.002721:0.003235:0.002721:0.008920:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.003235:0.002721:0.005564:0.003235:0.005564:0.008890:0.010009:0.009525:0.004248:0.002721:0.013879:0.010009:0.009601:0.005564:0.009525:0.010054:0.003235:0.009601:0.009223:0.004188
a viral infection. The differential diagnosis for an exacerba-:@0.076188:0.789102:0.480970:0.789102:0.480970:0.773319:0.076188:0.773319:0.010024:0.003251:0.008074:0.002721:0.004248:0.010024:0.002721:0.003266:0.002721:0.008920:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.003886:0.003251:0.006138:0.008920:0.009525:0.003251:0.010054:0.002721:0.004445:0.004445:0.009525:0.004248:0.009525:0.008920:0.004823:0.002721:0.010024:0.002721:0.003266:0.010054:0.002721:0.010024:0.009873:0.008920:0.009601:0.005564:0.002721:0.005564:0.003266:0.004445:0.009601:0.004248:0.003266:0.010024:0.008920:0.003266:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.005020
tion is biventricular cardiac failure, pulmonary embolism, :@0.076188:0.803164:0.485098:0.803164:0.485098:0.787382:0.076188:0.787382:0.004823:0.002721:0.009601:0.008920:0.005549:0.002721:0.005564:0.005549:0.010009:0.002721:0.008074:0.009525:0.008920:0.004823:0.004248:0.002721:0.009480:0.008890:0.002721:0.010024:0.004248:0.005549:0.009480:0.010024:0.004248:0.010054:0.002721:0.010024:0.009480:0.005549:0.004445:0.010024:0.002721:0.002721:0.008890:0.004248:0.009525:0.003886:0.005549:0.010009:0.008890:0.002721:0.013879:0.009601:0.008920:0.010024:0.004248:0.007801:0.005549:0.009525:0.013879:0.010009:0.009601:0.002721:0.002721:0.005564:0.013879:0.004188:0.004188
pneumonia and acute coronary syndrome.   since pa-:@0.076188:0.817227:0.480947:0.817254:0.480947:0.801472:0.076188:0.801444:0.010009:0.008920:0.009525:0.008890:0.013879:0.009601:0.008920:0.002721:0.010024:0.007590:0.010024:0.008920:0.010054:0.007590:0.010024:0.009480:0.008890:0.004823:0.009525:0.007590:0.009480:0.009601:0.004248:0.009601:0.008920:0.010024:0.004248:0.007801:0.007590:0.005564:0.007801:0.008920:0.010054:0.004248:0.009601:0.013879:0.009525:0.004188:0.004361:0.004188:0.003402:0.007227:0.002721:0.008920:0.009480:0.009525:0.007590:0.010009:0.010024:-0.215950
1:@0.398157:0.811956:0.403016:0.811956:0.403016:0.802802:0.398157:0.802802:0.004858
tients with COpD often have comorbidities, these alterna-:@0.076195:0.831317:0.480962:0.831317:0.480962:0.815534:0.076195:0.815534:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.004127:0.012262:0.002721:0.004823:0.008920:0.004127:0.011989:0.012836:0.008648:0.010946:0.004127:0.009601:0.004445:0.004823:0.009525:0.008920:0.004127:0.008920:0.010024:0.008074:0.009525:0.004127:0.009480:0.009601:0.013879:0.009601:0.004248:0.010009:0.002721:0.010054:0.002721:0.004823:0.002721:0.009525:0.005564:0.003886:0.004127:0.004823:0.008920:0.009525:0.005564:0.009525:0.004127:0.010024:0.002721:0.004823:0.009525:0.004248:0.008920:0.010024:0.005020
tive diagnoses should be considered.:@0.076195:0.845379:0.337890:0.845379:0.337890:0.829596:0.076195:0.829596:0.004823:0.002721:0.008074:0.009525:0.003886:0.010054:0.002721:0.010024:0.009873:0.008920:0.009601:0.005564:0.009525:0.005564:0.003886:0.005564:0.008920:0.009601:0.008890:0.002721:0.010054:0.003886:0.010009:0.009525:0.003886:0.009480:0.009601:0.008920:0.005564:0.002721:0.010054:0.009525:0.004248:0.009525:0.010054:0.004188
mAnAGement:@0.076190:0.878205:0.206651:0.878205:0.206651:0.858040:0.076190:0.858040:0.016631:0.013674:0.013674:0.013674:0.015522:0.009609:0.016631:0.009609:0.013674:0.007761
non-pharmacological treatment:@0.076190:0.900859:0.341949:0.900859:0.341949:0.882527:0.076190:0.882527:0.012431:0.010751:0.010079:0.007056:0.011087:0.010079:0.011087:0.005376:0.015791:0.011087:0.010751:0.010751:0.004032:0.010751:0.011087:0.004032:0.010751:0.011087:0.004032:0.004704:0.005040:0.005376:0.010751:0.011087:0.005040:0.015791:0.010751:0.010079:0.005040
smoking cessation is the most critical intervention in the :@0.076190:0.917099:0.485145:0.917099:0.485145:0.901316:0.076190:0.901316:0.007529:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004309:0.009782:0.009827:0.005866:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004324:0.003024:0.005866:0.004324:0.005125:0.009223:0.009827:0.004309:0.014182:0.009903:0.005866:0.005125:0.004324:0.009782:0.004551:0.003024:0.005125:0.003024:0.009782:0.010326:0.003024:0.004324:0.003024:0.009223:0.005125:0.009827:0.004551:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004309:0.003024:0.009223:0.004324:0.005125:0.009223:0.009827:0.004188
management of COpD. The average loss of the forced :@0.076190:0.931161:0.485130:0.931161:0.485130:0.915378:0.076190:0.915378:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004536:0.009903:0.004747:0.004536:0.012292:0.013138:0.008950:0.011249:0.004188:0.004551:0.006441:0.009223:0.009827:0.004536:0.010326:0.008376:0.009827:0.004551:0.010326:0.010175:0.009827:0.004536:0.003024:0.009903:0.005866:0.005866:0.004551:0.009903:0.004747:0.004536:0.005125:0.009223:0.009827:0.004536:0.004747:0.009903:0.004551:0.009782:0.009827:0.010357:0.004188
expiratory volume in one second (FEV ) per year in the :@0.076190:0.945362:0.485158:0.945363:0.485158:0.929580:0.076190:0.929579:0.009827:0.007257:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.005004:0.008376:0.009903:0.003024:0.009192:0.014182:0.009827:0.005020:0.003024:0.009223:0.005020:0.009903:0.009223:0.009827:0.005004:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.005020:0.005579:0.007333:0.008104:0.010614:0.004866:0.005579:0.005020:0.010311:0.009827:0.004551:0.005020:0.008104:0.009827:0.010326:0.004551:0.005020:0.003024:0.009223:0.005020:0.005125:0.009223:0.009827:-0.388753
1:@0.356533:0.945029:0.361392:0.945029:0.361392:0.935875:0.356533:0.935875:0.004858
non-smoker is about 25 ml. In smokers, the average loss :@0.519055:0.469956:0.927979:0.469956:0.927979:0.454173:0.519055:0.454173:0.009223:0.009903:0.009223:0.005020:0.005866:0.014182:0.009903:0.007590:0.009827:0.004551:0.004505:0.003024:0.005866:0.004536:0.010326:0.010311:0.009903:0.009192:0.005125:0.004521:0.008376:0.008376:0.004536:0.014182:0.003024:0.004188:0.004521:0.003417:0.009223:0.004521:0.005866:0.014182:0.009903:0.007590:0.009827:0.004551:0.005866:0.004188:0.004521:0.005125:0.009223:0.009827:0.004521:0.010326:0.008376:0.009827:0.004551:0.010326:0.010175:0.009827:0.004521:0.003024:0.009903:0.005866:0.005866:0.004188
can approximate 40 ml per year. Initially, there is a gain :@0.519055:0.484792:0.927994:0.484792:0.927994:0.469009:0.519055:0.469009:0.009782:0.010326:0.009223:0.004158:0.010326:0.010311:0.010311:0.004551:0.009903:0.007257:0.003024:0.014182:0.010326:0.005125:0.009827:0.004158:0.008376:0.008376:0.004173:0.014182:0.003024:0.004173:0.010311:0.009827:0.004551:0.004158:0.008104:0.009827:0.010326:0.004551:0.004188:0.004158:0.003417:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188:0.004173:0.005125:0.009223:0.009827:0.004551:0.009827:0.004158:0.003024:0.005866:0.004173:0.010326:0.004158:0.010175:0.010326:0.003024:0.009223:0.004188
of about 50 ml in the FEV:@0.519055:0.499628:0.708874:0.499628:0.708874:0.483845:0.519055:0.483845:0.009903:0.004747:0.005639:0.010326:0.010311:0.009903:0.009192:0.005125:0.005639:0.008376:0.008376:0.005655:0.014182:0.003024:0.005655:0.003024:0.009223:0.005655:0.005125:0.009223:0.009827:0.005639:0.007333:0.008104:0.010614
1:@0.708866:0.499302:0.713724:0.499302:0.713724:0.490148:0.708866:0.490148:0.004858
 for the first year after smok:@0.713726:0.499636:0.918770:0.499636:0.918770:0.483854:0.713726:0.483854:0.005639:0.004747:0.009903:0.004551:0.005639:0.005125:0.009223:0.009827:0.005639:0.003681:0.003681:0.004551:0.005866:0.005125:0.005639:0.008104:0.009827:0.010326:0.004551:0.005639:0.010326:0.004747:0.005125:0.009827:0.004551:0.005639:0.005866:0.014182:0.009903:0.007590
-:@0.918770:0.499636:0.923789:0.499636:0.923789:0.483854:0.918770:0.483854:0.005020
ing  cessation.  Thereafter,  FEV   loss approximates that :@0.519053:0.514472:0.928006:0.514474:0.928006:0.498691:0.519053:0.498690:0.003024:0.009223:0.010175:0.004188:0.003175:0.009782:0.009827:0.005866:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.003175:0.006441:0.009223:0.009827:0.004551:0.009827:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188:0.004188:0.003160:0.007333:0.008104:0.010614:0.004867:0.004188:0.003175:0.003024:0.009903:0.005866:0.005866:0.007378:0.010326:0.010311:0.010311:0.004551:0.009903:0.007257:0.003024:0.014182:0.010326:0.005125:0.009827:0.005866:0.007378:0.005125:0.009223:0.010326:0.005125:-0.267343
1:@0.741370:0.514140:0.746228:0.514140:0.746228:0.504986:0.741370:0.504986:0.004858
of a non-smoker.   smokers manage to quit at a rate :@0.519051:0.529310:0.928008:0.529312:0.928008:0.513529:0.519051:0.513527:0.009903:0.004747:0.007076:0.010326:0.007076:0.009223:0.009903:0.009223:0.005020:0.005866:0.014182:0.009903:0.007590:0.009827:0.004551:0.004188:0.004840:0.004188:0.002888:0.007529:0.014182:0.009903:0.007590:0.009827:0.004551:0.005866:0.007076:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.007076:0.005125:0.009903:0.007076:0.010311:0.009192:0.003024:0.005125:0.007076:0.010326:0.005125:0.007076:0.010326:0.007076:0.004551:0.010326:0.005125:0.009827:-0.286774
8:@0.647634:0.524013:0.652492:0.524013:0.652492:0.514859:0.647634:0.514859:0.004858
of about 1% per annum, but if medical advice is given :@0.519053:0.544147:0.927993:0.544147:0.927993:0.528365:0.519053:0.528365:0.009903:0.004747:0.004989:0.010326:0.010311:0.009903:0.009192:0.005125:0.005004:0.008376:0.011717:0.005004:0.010311:0.009827:0.004551:0.004989:0.010326:0.009223:0.009223:0.009192:0.014182:0.004188:0.004989:0.010311:0.009192:0.005125:0.005004:0.003024:0.004747:0.005004:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.005004:0.010326:0.010357:0.008376:0.003024:0.009782:0.009827:0.005004:0.003024:0.005866:0.005004:0.010175:0.003024:0.008376:0.009827:0.009223:0.004188
about the benefits of quitting, an increase to about 3% :@0.519053:0.558983:0.927993:0.558983:0.927993:0.543201:0.519053:0.543201:0.010326:0.010311:0.009903:0.009192:0.005125:0.004687:0.005125:0.009223:0.009827:0.004687:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.004687:0.009903:0.004747:0.004687:0.010311:0.009192:0.003024:0.005125:0.005125:0.003024:0.009223:0.010175:0.004188:0.004687:0.010326:0.009223:0.004687:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004687:0.005125:0.009903:0.004687:0.010326:0.010311:0.009903:0.009192:0.005125:0.004687:0.008376:0.011717:0.004188
of smokers who quit can be reached.:@0.519053:0.573819:0.793509:0.573819:0.793509:0.558037:0.519053:0.558037:0.009903:0.004747:0.004188:0.005866:0.014182:0.009903:0.007590:0.009827:0.004551:0.005866:0.004188:0.012564:0.009223:0.009903:0.004188:0.010311:0.009192:0.003024:0.005125:0.004188:0.009782:0.010326:0.009223:0.004188:0.010311:0.009827:0.004188:0.004551:0.009827:0.010326:0.009782:0.009223:0.009827:0.010357:0.004188
8:@0.793471:0.568526:0.798329:0.568526:0.798329:0.559372:0.793471:0.559372:0.004858
pulmonary rehabilitation takes the form of any exer-:@0.533333:0.588662:0.923827:0.588662:0.923827:0.572879:0.533333:0.572879:0.008950:0.009192:0.003024:0.014182:0.009903:0.009223:0.010326:0.004551:0.008104:0.005987:0.004551:0.009827:0.009223:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.006002:0.005125:0.010326:0.007590:0.009827:0.005866:0.005987:0.005125:0.009223:0.009827:0.005987:0.004747:0.009903:0.004551:0.014182:0.005987:0.009903:0.004747:0.005987:0.010326:0.009223:0.008104:0.005987:0.009827:0.007257:0.009827:0.004551:0.005020
cise that uses the major muscle groups for 20 minutes :@0.519045:0.603498:0.928000:0.603498:0.928000:0.587715:0.519045:0.587715:0.009782:0.003024:0.005866:0.009827:0.006138:0.005125:0.009223:0.010326:0.005125:0.006138:0.009192:0.005866:0.009827:0.005866:0.006138:0.005125:0.009223:0.009827:0.006138:0.014182:0.010326:0.003069:0.009903:0.004551:0.006138:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.006138:0.010175:0.004551:0.009903:0.009192:0.010311:0.005866:0.006138:0.004747:0.009903:0.004551:0.006138:0.008376:0.008376:0.006138:0.014182:0.003024:0.009223:0.009192:0.005125:0.009827:0.005866:0.004188
for two to three sessions per week. The common types :@0.519045:0.618334:0.927970:0.618334:0.927970:0.602551:0.519045:0.602551:0.004747:0.009903:0.004551:0.005367:0.005125:0.012564:0.009903:0.005382:0.005125:0.009903:0.005367:0.005125:0.009223:0.004551:0.009827:0.009812:0.005382:0.005866:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.005866:0.005382:0.010311:0.009827:0.004551:0.005367:0.012564:0.009827:0.009827:0.007590:0.004188:0.005367:0.006441:0.009223:0.009827:0.005367:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.005367:0.005125:0.008104:0.010311:0.009827:0.005866:0.004188
of exercise would be brisk walking or static cycling. The :@0.519045:0.633169:0.928000:0.633169:0.928000:0.617387:0.519045:0.617387:0.009903:0.004747:0.004581:0.009827:0.007257:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827:0.004581:0.012564:0.009903:0.009192:0.003024:0.010357:0.004581:0.010311:0.009827:0.004581:0.010311:0.004551:0.003024:0.005866:0.007590:0.004581:0.012564:0.010326:0.003024:0.007590:0.003024:0.009223:0.010175:0.004581:0.009903:0.004551:0.004566:0.005866:0.005125:0.010326:0.005125:0.003024:0.009782:0.004581:0.009782:0.008104:0.009782:0.003024:0.003024:0.009223:0.010175:0.004188:0.004581:0.006441:0.009223:0.009827:0.004188
intensity of the activity need not be very high in order for :@0.519045:0.648005:0.928000:0.648005:0.928000:0.632223:0.519045:0.632223:0.003024:0.009223:0.005125:0.009827:0.009223:0.005866:0.003024:0.005125:0.008104:0.003432:0.009903:0.004747:0.003432:0.005125:0.009223:0.009827:0.003432:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.003447:0.009223:0.009827:0.009827:0.010357:0.003432:0.009223:0.009903:0.005125:0.003432:0.010311:0.009827:0.003432:0.008376:0.009827:0.004551:0.008104:0.003432:0.009223:0.003024:0.010175:0.009223:0.003432:0.003024:0.009223:0.003432:0.009903:0.004551:0.010357:0.009827:0.004551:0.003417:0.004747:0.009903:0.004551:0.004188
the patient to notice the health benefits.:@0.519045:0.662841:0.815878:0.662841:0.815878:0.647059:0.519045:0.647059:0.005125:0.009223:0.009827:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188:0.005125:0.009903:0.004188:0.009223:0.009903:0.005125:0.003024:0.009782:0.009827:0.004188:0.005125:0.009223:0.009827:0.004188:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.004188:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.004188
8:@0.815832:0.657551:0.820690:0.657551:0.820690:0.648397:0.815832:0.648397:0.004858
Annual influenza vaccination:@0.519047:0.687061:0.755912:0.687061:0.755912:0.668729:0.519047:0.668729:0.012431:0.010079:0.010079:0.010079:0.011087:0.004032:0.004704:0.004032:0.010079:0.004368:0.004368:0.010079:0.010751:0.010079:0.007728:0.011087:0.004704:0.009407:0.011087:0.010751:0.010751:0.004032:0.010079:0.011087:0.005040:0.004032:0.010751:0.010079
Viral infections cause acute exacerbation of COpD in :@0.519047:0.704070:0.928032:0.704070:0.928032:0.688288:0.519047:0.688288:0.010311:0.002721:0.004248:0.010024:0.002721:0.007937:0.002721:0.008920:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.005564:0.007937:0.009480:0.010024:0.008890:0.005564:0.009525:0.007937:0.010024:0.009480:0.008890:0.004823:0.009525:0.007937:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.007937:0.009601:0.004445:0.007937:0.011989:0.012836:0.008648:0.010946:0.007937:0.002721:0.009223:0.004188
about a third of patients and make the bronchial epithe-:@0.519047:0.718906:0.923814:0.718906:0.923814:0.703123:0.519047:0.703123:0.010024:0.010009:0.009601:0.008890:0.004823:0.004445:0.010024:0.004445:0.004823:0.008920:0.002721:0.004248:0.010054:0.004445:0.009601:0.004445:0.004445:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.004445:0.010024:0.008920:0.010054:0.004445:0.013879:0.010024:0.007287:0.009525:0.004445:0.004823:0.008920:0.009525:0.004445:0.010009:0.004248:0.009601:0.008920:0.009480:0.008920:0.002721:0.010024:0.002721:0.004445:0.009525:0.010009:0.002721:0.004823:0.008920:0.009525:0.005020
lium susceptible to bacterial co-infection. Vaccination has :@0.519047:0.733742:0.928002:0.733742:0.928002:0.717959:0.519047:0.717959:0.002721:0.002721:0.008890:0.013879:0.003175:0.005564:0.008890:0.005564:0.009480:0.009525:0.010009:0.004823:0.002721:0.010009:0.002721:0.009525:0.003175:0.004823:0.009601:0.003175:0.010009:0.010024:0.009480:0.004823:0.009525:0.004248:0.002721:0.010024:0.002721:0.003175:0.009480:0.009601:0.004717:0.002721:0.008920:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.003886:0.003175:0.010311:0.010024:0.009480:0.009480:0.002721:0.008920:0.010024:0.004823:0.002721:0.009601:0.008920:0.003175:0.008920:0.010024:0.005866:0.004188
a protective effect by limiting the risk of exacerbation by :@0.519047:0.748578:0.927941:0.748578:0.927941:0.732795:0.519047:0.732795:0.010024:0.004702:0.010009:0.004248:0.009601:0.004823:0.009525:0.009480:0.004823:0.002721:0.008074:0.009525:0.004702:0.009525:0.004445:0.004445:0.009525:0.009480:0.004823:0.004702:0.010009:0.007801:0.004702:0.002721:0.002721:0.013879:0.002721:0.004823:0.002721:0.008920:0.009873:0.004702:0.004823:0.008920:0.009525:0.004702:0.004248:0.002721:0.005564:0.007287:0.004702:0.009601:0.004445:0.004702:0.009525:0.006955:0.010024:0.009480:0.009525:0.004248:0.010009:0.010024:0.004823:0.002721:0.009601:0.008920:0.004702:0.010009:0.008104:0.004188
up to four-fold, compared to non-vaccinated patients.:@0.519047:0.763414:0.905414:0.763414:0.905414:0.747631:0.519047:0.747631:0.008890:0.010009:0.003886:0.004823:0.009601:0.003886:0.004445:0.009601:0.008890:0.004248:0.004717:0.004445:0.009601:0.002721:0.010054:0.003886:0.003886:0.009480:0.009601:0.013879:0.010009:0.010024:0.004248:0.009525:0.010054:0.003886:0.004823:0.009601:0.003886:0.008920:0.009601:0.008920:0.004717:0.008074:0.010024:0.009480:0.009480:0.002721:0.008920:0.010024:0.004823:0.009525:0.010054:0.003886:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.004188
9:@0.905071:0.758122:0.909929:0.758122:0.909929:0.748968:0.905071:0.748968:0.004858
Pneumococcal vaccination:@0.519047:0.795328:0.745833:0.795328:0.745833:0.776997:0.519047:0.776997:0.009407:0.010079:0.010751:0.010079:0.015791:0.010751:0.010751:0.010751:0.010751:0.010751:0.011087:0.004032:0.004704:0.009407:0.011087:0.010751:0.010751:0.004032:0.010079:0.011087:0.005040:0.004032:0.010751:0.010079
since :@0.519047:0.812338:0.562620:0.812338:0.562620:0.796555:0.519047:0.796555:0.007529:0.003024:0.009223:0.009782:0.009827:0.004188
Streptococcus pneumoniae:@0.563164:0.812338:0.769585:0.812338:0.769585:0.796555:0.563164:0.796555:0.007529:0.005125:0.004551:0.009827:0.010311:0.005125:0.009903:0.009767:0.009903:0.009782:0.009782:0.009192:0.005866:0.004732:0.010311:0.009223:0.009827:0.009192:0.014182:0.009888:0.009223:0.003024:0.010326:0.009827
 is the most common :@0.769585:0.812338:0.928002:0.812338:0.928002:0.796555:0.769585:0.796555:0.004732:0.003024:0.005866:0.004732:0.005125:0.009223:0.009827:0.004717:0.014182:0.009903:0.005866:0.005125:0.004732:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004188
causal organism in pneumonia, pneumococcal vacci-:@0.519047:0.827174:0.923799:0.827174:0.923799:0.811391:0.519047:0.811391:0.009782:0.010326:0.009192:0.005866:0.010326:0.003024:0.005171:0.009903:0.004551:0.010175:0.010326:0.009223:0.003024:0.005866:0.014182:0.005156:0.003024:0.009223:0.005156:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009223:0.003024:0.010326:0.004188:0.005156:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009782:0.009903:0.009782:0.009782:0.010326:0.003024:0.005156:0.008376:0.010326:0.009782:0.009782:0.003024:0.005020
nation prevents and decreases the severity of infection :@0.519047:0.842010:0.927987:0.842010:0.927987:0.826227:0.519047:0.826227:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004460:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004460:0.010326:0.009223:0.010357:0.004475:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.004475:0.005125:0.009223:0.009827:0.004460:0.005866:0.009827:0.008376:0.009827:0.004551:0.003024:0.005125:0.008104:0.004475:0.009903:0.004747:0.004475:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
in COpD patients.  patients under the age of 65 with the :@0.519047:0.856846:0.928011:0.856850:0.928011:0.841068:0.519047:0.841063:0.003024:0.009223:0.003356:0.012292:0.013138:0.008950:0.011249:0.003356:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.009715:0.003356:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003356:0.009192:0.009223:0.010357:0.009827:0.004551:0.003341:0.005125:0.009223:0.009827:0.003341:0.010326:0.010175:0.009827:0.003356:0.009903:0.004747:0.003356:0.008376:0.008376:0.003356:0.012564:0.003024:0.005125:0.009223:0.003356:0.005125:0.009223:0.009827:-0.715697
10:@0.646648:0.851552:0.656364:0.851552:0.656364:0.842398:0.646648:0.842398:0.004858:0.004858
same degree of FEV:@0.519041:0.871686:0.669687:0.871686:0.669687:0.855904:0.519041:0.855904:0.005866:0.010326:0.014182:0.009827:0.005065:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.005050:0.009903:0.004747:0.005065:0.007333:0.008104:0.010614
1:@0.669704:0.871354:0.674562:0.871354:0.674562:0.862200:0.669704:0.862200:0.004858
 reduction, had a five times lower :@0.674563:0.871688:0.927989:0.871688:0.927989:0.855905:0.674563:0.855905:0.005065:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.005050:0.009223:0.010326:0.010357:0.005065:0.010326:0.005065:0.003681:0.003681:0.008376:0.009827:0.005065:0.005125:0.003024:0.014182:0.009827:0.005866:0.005065:0.003024:0.009903:0.012564:0.009827:0.004551:0.004188
incidence of  streptococcal  pneumonia  if vaccinated :@0.519049:0.886524:0.927989:0.886524:0.927989:0.870741:0.519049:0.870741:0.003024:0.009223:0.009782:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.006728:0.009903:0.004747:0.004188:0.002525:0.005866:0.005125:0.004551:0.009827:0.010311:0.005125:0.009903:0.009782:0.009903:0.009782:0.009782:0.010326:0.003024:0.004188:0.002525:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009223:0.003024:0.010326:0.004188:0.002525:0.003024:0.004747:0.006728:0.008376:0.010326:0.009782:0.009782:0.003024:0.009223:0.010326:0.005125:0.009827:0.010357:0.004188
with the 23 valent pneumococcal polysaccharide :@0.519049:0.901360:0.928004:0.901360:0.928004:0.885577:0.519049:0.885577:0.012564:0.003024:0.005125:0.009223:0.011672:0.005125:0.009223:0.009827:0.011672:0.008376:0.008376:0.011672:0.008376:0.010326:0.003024:0.009827:0.009223:0.005125:0.011672:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009782:0.009903:0.009782:0.009782:0.010326:0.003024:0.011672:0.010311:0.009903:0.003024:0.008104:0.005866:0.010326:0.009782:0.009782:0.009223:0.010326:0.004551:0.003024:0.010357:0.009827:0.004188
vaccine (ppV23).  After the age of 65, adults should be :@0.519049:0.916196:0.927988:0.916201:0.927988:0.900418:0.519049:0.900413:0.008376:0.010326:0.009782:0.009782:0.003024:0.009223:0.009827:0.004112:0.005579:0.008950:0.008950:0.010614:0.008376:0.008376:0.005579:0.004188:0.009720:0.004112:0.011188:0.004747:0.005125:0.009827:0.004551:0.004097:0.005125:0.009223:0.009827:0.004097:0.010326:0.010175:0.009827:0.004097:0.009903:0.004747:0.004097:0.008376:0.008376:0.004188:0.004112:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.004112:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004112:0.010311:0.009827:-0.793395
11:@0.644114:0.910902:0.653831:0.910902:0.653831:0.901748:0.644114:0.901748:0.004858:0.004858
vaccinated with a pneumococcal conjugate vaccine :@0.519048:0.930783:0.927972:0.930783:0.927972:0.915000:0.519048:0.915000:0.008376:0.010326:0.009782:0.009782:0.003024:0.009223:0.010326:0.005125:0.009827:0.010357:0.005231:0.012564:0.003024:0.005125:0.009223:0.005231:0.010326:0.005231:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009782:0.009888:0.009782:0.009782:0.010326:0.003024:0.005231:0.009782:0.009903:0.009223:0.003069:0.009192:0.010175:0.010326:0.005125:0.009827:0.005216:0.008376:0.010326:0.009782:0.009782:0.003024:0.009223:0.009827:0.004188
(pCV13) as this is effective in preventing  pneumonia :@0.519048:0.945365:0.928003:0.945365:0.928003:0.929582:0.519048:0.929582:0.005579:0.008950:0.012292:0.010614:0.008376:0.008376:0.005579:0.007756:0.010326:0.005866:0.007756:0.005125:0.009223:0.003024:0.005866:0.007756:0.003024:0.005866:0.007756:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.007756:0.003024:0.009223:0.007756:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009223:0.010175:0.004188:0.003553:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009223:0.003024:0.010326:0.004188
figure 1. Pathophysiology of COPD : interplay of cytokines released by alveolar epithelial cells and macrophages :@0.076196:0.424030:0.909614:0.424028:0.909614:0.407530:0.076196:0.407531:0.007257:0.003629:0.009979:0.009071:0.004838:0.009676:0.004233:0.008467:0.004233:0.004233:0.008467:0.009979:0.004536:0.009071:0.009676:0.009979:0.009071:0.008769:0.006652:0.003629:0.009676:0.003629:0.009676:0.009979:0.008769:0.004233:0.009676:0.004233:0.004233:0.011793:0.012700:0.008467:0.010583:0.004894:0.004233:0.004233:0.003629:0.009071:0.004536:0.009676:0.004838:0.009979:0.003629:0.009979:0.008769:0.004233:0.009676:0.004233:0.004233:0.009676:0.008769:0.004536:0.009676:0.008769:0.003629:0.009071:0.009676:0.006652:0.004233:0.004838:0.009676:0.003629:0.009676:0.009979:0.006652:0.009676:0.009979:0.004233:0.009979:0.008769:0.004233:0.009979:0.003629:0.008467:0.009676:0.009676:0.003629:0.009979:0.004838:0.004233:0.009676:0.009979:0.003629:0.004536:0.009071:0.009676:0.003629:0.003629:0.009979:0.003629:0.004233:0.009676:0.009676:0.003629:0.003629:0.006652:0.004233:0.009979:0.009071:0.009979:0.004233:0.014212:0.009979:0.009676:0.004838:0.009676:0.009979:0.009071:0.009979:0.009979:0.009676:0.006652:-0.129526
5:@0.329272:0.418729:0.334182:0.418729:0.334182:0.409160:0.329272:0.409160:0.004911
causing the pathophysiology of COPD:@0.076192:0.438137:0.354987:0.438137:0.354987:0.421638:0.076192:0.421638:0.009676:0.009979:0.009071:0.006652:0.003629:0.009071:0.009979:0.004233:0.004536:0.009071:0.009676:0.004233:0.009979:0.009979:0.004536:0.009071:0.009676:0.009979:0.009071:0.008769:0.006652:0.003629:0.009676:0.003629:0.009676:0.009979:0.008769:0.004233:0.009676:0.004233:0.004233:0.011793:0.012700:0.008467:0.010583
Cigarette smoke, biomass fuel fumes and inhaled irritants:@0.217962:0.083575:0.588587:0.083575:0.588587:0.069546:0.217962:0.069546:0.010926:0.002688:0.009045:0.009179:0.004045:0.008735:0.004556:0.004556:0.008735:0.003723:0.005214:0.012606:0.008803:0.006746:0.008735:0.003723:0.003723:0.009165:0.002688:0.008803:0.012606:0.009179:0.005214:0.005214:0.003723:0.004220:0.008171:0.008735:0.002688:0.003723:0.004220:0.008171:0.012606:0.008735:0.005214:0.003723:0.009179:0.008198:0.009206:0.003723:0.002688:0.008198:0.008198:0.009179:0.002688:0.008735:0.009206:0.003723:0.002688:0.004045:0.004045:0.002688:0.004556:0.009179:0.008198:0.004556:0.005214
Alveolar macrophages:@0.422251:0.161664:0.572366:0.161664:0.572366:0.147635:0.422251:0.147635:0.009945:0.002688:0.007445:0.008735:0.008803:0.002688:0.009179:0.004045:0.003723:0.012606:0.009179:0.008695:0.004045:0.008803:0.009165:0.008198:0.009179:0.009045:0.008735:0.005214
Epithelial cells:@0.212640:0.161664:0.302172:0.161664:0.302172:0.147635:0.212640:0.147635:0.007203:0.009165:0.002688:0.004556:0.008198:0.008735:0.002688:0.002688:0.009179:0.002688:0.003723:0.008695:0.008735:0.002688:0.002688:0.005214
TNF-a, IL-1b, IL-6, GM-CsF and :@0.152205:0.204705:0.348537:0.204705:0.348537:0.190676:0.152205:0.190676:0.005725:0.009945:0.006518:0.004462:0.009179:0.003723:0.003723:0.003037:0.006209:0.004462:0.007445:0.009165:0.003723:0.003723:0.003037:0.006209:0.004462:0.007445:0.003723:0.003723:0.011719:0.012351:0.004462:0.010926:0.006693:0.006518:0.003723:0.009179:0.008198:0.009206:0.003723
IL-8 and TGF-b:@0.152205:0.217533:0.244975:0.217533:0.244975:0.203504:0.152205:0.203504:0.003037:0.006209:0.004462:0.007445:0.003723:0.009179:0.008198:0.009206:0.003723:0.005725:0.011719:0.006518:0.004462:0.009165
TNF-a,  CXCL1, CXCL8, CCL2 (monocyte  chemo-:@0.408812:0.204705:0.751510:0.204705:0.751510:0.190676:0.408812:0.190676:0.005725:0.009945:0.006518:0.004462:0.009179:0.003723:0.003723:0.006021:0.010926:0.008184:0.010926:0.006209:0.007445:0.003723:0.009757:0.010926:0.008184:0.010926:0.006209:0.007445:0.003723:0.009757:0.010926:0.010926:0.006209:0.007445:0.009757:0.004959:0.012606:0.008803:0.008198:0.008803:0.008695:0.007203:0.004556:0.008735:0.003723:0.006021:0.008695:0.008198:0.008735:0.012606:0.008803:0.004462
attractant protein 1), leukotriene (LT)B4:@0.408812:0.217533:0.661830:0.217533:0.661830:0.203504:0.408812:0.203504:0.009179:0.004556:0.004556:0.004045:0.009179:0.008695:0.004556:0.009179:0.008198:0.004556:0.003723:0.009165:0.004045:0.008803:0.004556:0.008735:0.002688:0.008198:0.003723:0.007445:0.004959:0.003723:0.003723:0.002688:0.008735:0.008171:0.006746:0.008803:0.004556:0.004045:0.002688:0.008735:0.008198:0.008735:0.003723:0.004959:0.006209:0.005725:0.004959:0.007714:0.007445
Neutrophils,  lymphocytes, eosinophils are attracted :@0.155820:0.283368:0.501233:0.283368:0.501233:0.269339:0.155820:0.269339:0.009945:0.008735:0.008171:0.004556:0.004045:0.008803:0.009165:0.008198:0.002688:0.002688:0.005214:0.003723:0.003723:0.002244:0.002688:0.007203:0.012606:0.009165:0.008198:0.008803:0.008695:0.007203:0.004556:0.008735:0.005214:0.003723:0.005980:0.008735:0.008803:0.005214:0.002688:0.008198:0.008803:0.009165:0.008198:0.002688:0.002688:0.005214:0.005980:0.009179:0.004045:0.008735:0.005980:0.009179:0.004556:0.004556:0.004045:0.009179:0.008695:0.004556:0.008735:0.009206:0.003723
into the lung by chemokine mediators:@0.155820:0.296196:0.403073:0.296196:0.403073:0.282167:0.155820:0.282167:0.002688:0.008198:0.004556:0.008803:0.003723:0.004556:0.008198:0.008735:0.003723:0.002688:0.008171:0.008198:0.009045:0.003723:0.009165:0.007203:0.003723:0.008695:0.008198:0.008735:0.012606:0.008803:0.006746:0.002688:0.008198:0.008735:0.003723:0.012606:0.008735:0.009206:0.002688:0.009179:0.004556:0.008803:0.004045:0.005214
Alveolar destruction, mucous hypersecretion – :@0.219320:0.338365:0.523447:0.338365:0.523447:0.324336:0.219320:0.324336:0.009945:0.002688:0.007445:0.008735:0.008803:0.002688:0.009179:0.004045:0.003723:0.009206:0.008735:0.005214:0.004556:0.004045:0.008171:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.012606:0.008171:0.008695:0.008803:0.008171:0.005214:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.005214:0.008735:0.008695:0.004045:0.008735:0.004556:0.002688:0.008803:0.008198:0.003723:0.006720:0.003723
airflow obstruction (neutrophils). Hyperactivity :@0.219320:0.351194:0.518945:0.351194:0.518945:0.337165:0.219320:0.337165:0.009179:0.002688:0.004045:0.003259:0.003259:0.008803:0.011168:0.003723:0.008803:0.009165:0.005214:0.004556:0.004045:0.008171:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.004959:0.008198:0.008735:0.008171:0.004556:0.004045:0.008803:0.009165:0.008198:0.002688:0.002688:0.005214:0.004959:0.003723:0.003723:0.009179:0.007203:0.009165:0.008735:0.004045:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723
asthma-like symptoms (eosinophils).:@0.219320:0.364022:0.450419:0.364022:0.450419:0.349993:0.219320:0.349993:0.009179:0.005214:0.004556:0.008198:0.012606:0.009179:0.004462:0.002688:0.002688:0.006746:0.008735:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.004959:0.008735:0.008803:0.005214:0.002688:0.008198:0.008803:0.009165:0.008198:0.002688:0.002688:0.005214:0.004959:0.003723
Increased neutrophil infiltration and alveolar :@0.219320:0.376850:0.509713:0.376850:0.509713:0.362821:0.219320:0.362821:0.003037:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.009206:0.003723:0.008198:0.008735:0.008171:0.004556:0.004045:0.008803:0.009165:0.008198:0.002688:0.002688:0.003723:0.002688:0.008198:0.003272:0.003272:0.002688:0.004556:0.004045:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.009179:0.008198:0.009206:0.003723:0.009179:0.002688:0.007445:0.008735:0.008803:0.002688:0.009179:0.004045:0.003723
destruction (lymphocytes):@0.219320:0.389678:0.388895:0.389678:0.388895:0.375649:0.219320:0.375649:0.009206:0.008735:0.005214:0.004556:0.004045:0.008171:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.004959:0.002688:0.007203:0.012606:0.009165:0.008198:0.008803:0.008695:0.007203:0.004556:0.008735:0.005214:0.004959